Cannabis for Vaping
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial examines how different doses of THC, the active ingredient in cannabis, affect people who use e-cigarettes. Researchers aim to understand THC's impact on cravings, mood, heart rate, and other physical responses. Participants will try both smoked and vaporized THC in a controlled setting. This trial suits healthy adults who use e-cigarettes daily and consume cannabis at least once a week. As a Phase 1 trial, the research focuses on understanding how the treatment works in people, offering participants the opportunity to be among the first to receive this treatment.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, you must not have a substance use disorder other than alcohol, cannabis, or nicotine, and you cannot test positive for illicit drugs other than cannabis and tobacco.
Is there any evidence suggesting that this treatment is likely to be safe for humans?
Research has shown some safety concerns with both smoked and vaporized THC (tetrahydrocannabinol). For vaporized THC, studies have found that although it may release fewer harmful chemicals than smoking, it has been linked to lung injuries. Additionally, insufficient long-term safety information about THC vaping products makes their safety uncertain.
For smoked THC, common side effects include red eyes, dry mouth, and drowsiness. It can also affect memory and cause anxiety. Long-term use might lead to cannabinoid hyperemesis syndrome, which causes severe nausea and vomiting.
Both smoked and vaporized THC can alter mood, thoughts, and perception. Some individuals might handle these effects well, while others might not. Consider these factors carefully when deciding to join a trial.12345Why are researchers excited about this trial's treatments?
Researchers are excited about these treatments because they explore a new way of delivering THC for potential therapeutic benefits, using both smoked and vaporized methods. Unlike traditional oral or topical cannabis treatments, these methods allow THC to be absorbed more rapidly through the lungs, which might lead to quicker effects. Additionally, the combination of THC with varying nicotine levels in e-cigarettes could offer insights into how these substances interact, potentially leading to more personalized and effective treatment options. This approach could open up new avenues for managing conditions that respond to THC, offering a fresh perspective on cannabis-based therapies.
What evidence suggests that this trial's treatments could be effective for e-cigarette users?
This trial will compare the effects of smoked THC with vaporized THC. Research has shown that vaping THC can produce stronger effects than smoking it. For instance, one study found that people who vaped a 25-milligram dose of THC experienced stronger effects on average than those who smoked the same amount. Both smoking and vaping THC can increase heart rate and blood pressure. Vaping typically results in higher levels of THC in the blood, leading to more noticeable effects. These findings suggest that both methods can significantly impact sensations and the body's response.678910
Who Is on the Research Team?
Dustin Lee, PhD
Principal Investigator
Johns Hopkins School of Medicine
Are You a Good Fit for This Trial?
This trial is for individuals who use e-cigarettes and smoke or vape THC. Participants must be willing to try different doses of THC in a controlled lab setting. Specific eligibility criteria are not provided, but typically include age range, health status, and frequency of cannabis and tobacco use.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive multiple doses of THC and placebo to assess the effects on e-cigarette use behavior
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- THC
THC is already approved in United States, Canada, European Union for the following indications:
- Appetite loss and weight loss in HIV
- Nausea and vomiting from chemotherapy
- Appetite loss and weight loss in HIV/AIDS
- Nausea and vomiting from chemotherapy
- Appetite loss and weight loss in HIV/AIDS
- Nausea and vomiting from chemotherapy
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Collaborator